| Возраст домена | n/a |
| Дата окончания | n/a |
| PR | 7 |
| ИКС | |
| Страниц в Google | 10700 |
| Страниц в Яндексе | 4000 |
| Dmoz | |
| Яндекс Каталог | Нет |
| Alexa Traffic Rank | 165677 |
| Alexa Country | 1372 |
| История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Medsafe Home Page
n/a
n/a
UTF-8
15.74 КБ
410
3 583 симв.
3 076 симв.
Данные предоставлены сервисом semrush
| Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
|---|---|---|---|---|---|---|
| 2321 | 6 |
50 | 21875 | 1897 | ||
| 778 | 7 |
30 | 22855 | 737 | ||
| 756 | 5 |
10 | 93864 | 25060 | ||
| 524 | 6 |
10 | 62211 | 2179 | ||
| 421 | 1 |
10 | 258345 | 86097 | ||
| 388 | 7 |
0 | 46468 | 10451 | ||
| 384 | 5 |
0 | 2893001 | Нет данных |
||
| 352 | 6 |
20 | 42295 | 1207 | ||
| 340 | 4 |
10 | 303890 | 5889 | ||
| 173 | 6 |
80 | 198509 | 23363 | ||
| 33 | 7 |
0 | 3848 | 1398 | ||
| 25 | 7 |
0 | Нет данных | Нет данных |
||
| 25 | 8 |
0 | 113 | 65 | ||
| 20 | 6 |
0 | 19976462 | Нет данных |
||
| 19 | 9 |
0 | 5 | 6 | ||
| 18 | 7 |
0 | 552 | 197 | ||
| 14 | 6 |
0 | 26456 | 18104 | ||
| 13 | 7 |
0 | 7347 | 1874 | ||
| 11 | 7 |
0 | 3797 | 1943 | ||
| Еще 31 сайт после авторизации | ||||||
Данные предоставлены сервисом semrush

| Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
|---|---|---|---|
| Нет доступа | Нет доступа | n/a | |
| Данные linkpad ( 10 Ноября 2016 ) | |
| Количество ссылок на сайт | 5927 |
| Количество доменов, которые ссылаются на сайт | 976 |
| Количество найденных анкоров | 1058 |
| Исходящие (внешние) ссылки домена | 1990 |
| Количество доменов, на которые ссылается сайт | 126 |
| Количество исходящих анкоров | 259 |
| Внешние ссылки главной страницы ( 2 ) | |
| govt.nz/ | / |
| health.govt.nz/ | <img> |
| Внутренние ссылки главной страницы ( 81 ) | |
| index.asp | 1 |
| Medicines/medicines-landing.asp | Medicines |
| Medicines/medicine-information.asp | Medicine Information |
| Medicines/regulatory-approval-process.asp | Approval Process |
| Medicines/regulatory-landing.asp | Regulatory Guidance |
| Medicines/clinical-trials.asp | Clinical Trials |
| profs/class/clascon.asp | Classification |
| Medicines/manufacturing.asp | Manufacturing |
| devices/devices-landing.asp | Devices |
| regulatory/DevicesNew/3WAND.asp | WAND |
| regulatory/DevicesNew/industry.asp | Regulatory Guidance |
| devices/Surgical%20Mesh/Landing.asp | Surgical Mesh |
| regulatory/DevicesNew/safety.asp | Safety Information |
| hot/ProductRecallInformation/ProductRecallHome.asp | Product Recalls |
| devices/education-and-information.asp | Device Information |
| safety/safety-landing.asp | Safety |
| safety/education-and-information.asp | Safety Information |
| safety/alerts.asp | Safety Communications |
| safety/ADR-reporting.asp | Adverse Reaction Reporting |
| compliance/compliance-landing.asp | Compliance |
| profs/RIss/unapp.asp | Unapproved Medicines |
| compliance/advertising.asp | Marketing |
| compliance/importing-medicines.asp | Importing Medicines |
| publications/publications-landing.asp | Publications |
| hot/MediaContents.asp | Media |
| publications/prescriber-update.asp | 6 |
| publications/oia.asp | OIA Releases |
| consultations/consultations-landing.asp | Consultations |
| consultations/current.asp | Consultation on proposed changes to current warning and advisory statements for paracetamol |
| consultations/closed.asp | Closed |
| consultations/outcome.asp | Outcomes |
| committees/committees-landing.asp | Committees |
| committees/mcc.asp | Medicines Classification |
| committees/maac.asp | Medicines Assessment Advisory |
| committees/marc.asp | Medicines Adverse Reactions |
| other/about.asp | Our Role |
| other/new.asp | What's New |
| other/contact.asp | 9 |
| other/people.asp | Our People |
| about/HistoryRegulation/HistoryRegulationContents.asp | History |
| profs/PUarticles.asp | Prescriber Update Volume 40 Number 4 dated December 2019 |
| Consumers/cons.asp | More... |
| Medicines/infoSearch.asp | 5 |
| Consumers/MIET/ImportMedicines.asp | Personal Importation of Medicines |
| Consumers/educational-material.asp | Consumer Information Leaflets |
| safety/report-a-problem.asp | How to Report a Problem |
| profs/profs.asp | More... |
| profs/ADR-training/story.html | ADR eLearning |
| regulatory/reg.asp | More... |
| /WAND/ | 7 |
| regulatory/DietarySupplements/Regulation.asp | Dietary Supplements |
| regulatory/forms.asp | Forms and Templates |
| regulatory/current-guidelines.asp | Regulatory Guidelines |
| regulatory/fees.asp | Schedule of Fees |
| Medicines/policy-statements/Out%20of%20Stock.asp | Out of Stock |
| regulatory/DbSearch.asp | Product/Application for Medicines |
| Projects/B1/ADRSearch.asp | Adverse Reactions |
| hot/Recalls/RecallSearch.asp | Recalls |
| profs/class/classintro.asp | Classification |
| regulatory/labelling.asp | Label Statements |
| publications/media/2019/MCCMinutes.asp | Medicines Classification Committee releases latest meeting minutes |
| profs/class/Minutes/2016-2020/mccMin10Oct2019.htm | Minutes of the 63rd meeting of the Medicines Classification Committee held in Wellington on 10 October 2019 |
| profs/class/dates.asp | Medicines Classification Committee - Dates and Deadlines |
| compliance/Marketing.asp | Marketing products which are not approved medicines |
| publications/media/2019/TakingMultipleMedicines.asp | Taking multiple medicines? Support the health care system by reporting suspected side effects this #MedSafetyWeek |
| committees/marc/Agenda180-5Dec2019.htm | Agenda for the 180th Medicines Adverse Reactions Committee meeting - 5 December 2019 |
| safety/Alerts/Cafergot%20Prohibited.asp | Consent to distribute Cafergot tablets (ergotamine tartrate 1 mg + caffeine 100 mg) will be prohibited under Section 36 of the M... |
| safety/Alerts/Dabigatran.asp | Possible risk of vasculitis with dabigatran (Pradaxa) |
| safety/Alerts/BreastImplants.asp | Update 7 November 2019 - Breast Implants and anaplastic large cell lymphoma |
| safety/Alerts/Lamotrigine.asp | Suspected adverse reaction reports to lamotrigine after changing brands |
| safety/Alerts/Everet.asp | Everet (levetiracetam) - supply and potential seizure control issues for patients |
| hot/RecallActionNoticesNew/25236.asp | Consumer level recall of one lot of Avonex Pen 30mcg in 0.5mL, Lot 1422362 |
| profs/adverse/Minutes179.htm | Minutes of the 179th Medicines Adverse Reactions Committee Meeting |
| safety/Alerts/MedicinesAndNDMA.asp | Medicines containing ranitidine and a potential impurity, N-nitrosodimethylamine (NDMA) |
| safety/Alerts/Losartan.asp | Losartan approved medicines supplied in New Zealand not affected by recalls overseas |
| safety/Alerts/NitrosamineImpurity.asp | Review of chemically synthesised active pharmaceutical ingredients for presence of nitrosamine impurity |
| other/siteinfo.asp | About this Site |
| faq-index.asp | FAQs |
| sitemap.htm | 2 |
| other/accesskeys.asp | 0 |
| #page-content | [ |
США - 67.202.219.28
SunGard Availability Services LP
Sungard Network Solutions
HTTP/1.1 200 OK
Cache-Control: private
Content-Length: 16115
Content-Type: text/html
Server: Microsoft-IIS/8.5
Set-Cookie: ASPSESSIONIDCGAQTSRD=MIPKDNBDFDOMBCJOMFMIKGKG; secure; path=/
X-Powered-By: ASP.NET
Date: Mon, 16 Dec 2019 02:13:07 GMT
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"
1372